Drug Shortage Report for TEVA-BUPROPION XL
| Report ID | 68580 |
| Drug Identification Number | 02439662 |
| Brand name | ACT BUPROPION XL |
| Common or Proper name | BUPROPION XL |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | BUPROPION HYDROCHLORIDE |
| Strength(s) | 300MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 90 |
| ATC code | N06AX |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2018-12-01 |
| Estimated end date | 2019-12-31 |
| Actual end date | 2019-11-21 |
| Shortage status | Resolved |
| Updated date | 2019-11-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v25 | 2019-11-22 | English | Compare |
| v24 | 2019-11-21 | French | Compare |
| v23 | 2019-11-21 | English | Compare |
| v22 | 2019-11-14 | French | Compare |
| v21 | 2019-11-14 | English | Compare |
| v20 | 2019-10-17 | French | Compare |
| v19 | 2019-10-17 | English | Compare |
| v18 | 2019-09-19 | French | Compare |
| v17 | 2019-09-19 | English | Compare |
| v16 | 2019-09-10 | French | Compare |
| v15 | 2019-09-10 | English | Compare |
| v14 | 2019-09-10 | French | Compare |
| v13 | 2019-09-10 | English | Compare |
| v12 | 2019-09-10 | French | Compare |
| v11 | 2019-09-10 | English | Compare |
| v10 | 2019-08-29 | French | Compare |
| v9 | 2019-08-29 | English | Compare |
| v8 | 2019-08-06 | French | Compare |
| v7 | 2019-08-06 | English | Compare |
| v6 | 2019-06-04 | French | Compare |